ProKidney

Contributing Author

Recent Articles by ProKidney

6 hours	ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025 PROK GlobeNewswire
Oct-29	ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference PROK GlobeNewswire
Oct-20	ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025 PROK GlobeNewswire
Aug-27	ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference PROK GlobeNewswire
Aug-12	ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates PROK GlobeNewswire
Jul-15	ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel PROK GlobeNewswire
Jul-09	ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference PROK GlobeNewswire
Jul-08	ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes PROK GlobeNewswire
Jul-01	ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware PROK GlobeNewswire
May-12	ProKidney Reports First Quarter 2025 Financial Results and Business Highlights PROK GlobeNewswire